Amrize Ltd (NYSE:AMRZ – Get Free Report) CTO Roald Brouwer purchased 3,000 shares of Amrize stock in a transaction dated Wednesday, March 11th. The stock was bought at an average cost of $58.72 per share, with a total value of $176,160.00. Following the completion of the transaction, the chief technology officer directly owned 16,257 shares of the company’s stock, valued at $954,611.04. This represents a 22.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Amrize Stock Down 1.9%
AMRZ traded down $1.14 on Wednesday, reaching $58.03. 1,191,449 shares of the company traded hands, compared to its average volume of 3,548,729. The stock’s 50 day moving average price is $57.80 and its 200-day moving average price is $53.59. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $65.94. The company has a market cap of $32.10 billion and a price-to-earnings ratio of 23.60. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10.
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to analyst estimates of $2.95 billion. The company’s revenue was down .4% on a year-over-year basis.
Institutional Investors Weigh In On Amrize
Analysts Set New Price Targets
AMRZ has been the subject of several recent research reports. Truist Financial increased their price objective on Amrize from $60.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, February 20th. Citigroup upped their target price on Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Stephens began coverage on Amrize in a research note on Friday, November 14th. They set an “overweight” rating and a $60.00 price target for the company. Vertical Research started coverage on Amrize in a research note on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target for the company. Finally, UBS Group increased their price objective on Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, January 8th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $64.14.
View Our Latest Analysis on Amrize
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
